The second-generation Optune Lua system

Patients remain at the heart of the work we do every day, including our innovations in the Optune Lua device for patients living with MPM

Learn about Optune Lua™. Smaller and lighter, designed to fit your patient's everyday life.

Original Optune® system

Original Optune Lua™ System

Second-generation Optune Lua system

Second generation Optune Lua™ system with easy access sleeve bag, battery [electric field generator] & transducer arrays Download device overview

Designed for more convenience, carrying comfort and usability—the second-generation Optune Lua system is:

More compact

  • Smaller-profile carrying case with easy grip texture

More convenient

  • 5 different ways to carry the device

Equipped with smart technology

  • Battery indicator alerts patients to change battery and light sensor auto-dims for night use

Loco-regional delivery of Tumor Treating Fields (TTFields) via transducer arrays provides antimitotic activity directly at the site of the malignancy1

  • TTFields are added to pemetrexed + cisplatin or carboplatin systemic therapies
  • The size and placement of transducer arrays are customized based on gender, body type, and tumor location Novocure® will provide a customized map for array placement based on patient-specific measurements and tumor location (determined via CT scans).
  • It is recommended that Optune Lua is turned on at least 75% of the time (18 hours per day)
    • Patients have the flexibility to decide which times of the day are best for them, including at night when sleeping
Loco-regional delivery of Tumor Treating Fields (TTFields) via transducer arrays

Array placement video

See how arrays are placed on your patient’s skin.

MPM, malignant pleural mesothelioma.

References: 1. Optune Lua. Instructions for Use for Unresectable Malignant Pleural Mesothelioma. Novocure; 2021. 2. Optune Lua. Patient Information and Operation Manual for Unresectable Malignant Pleural Mesothelioma. Novocure; 2021.

Next: MOA
Indications For Use
jump to isi

The Optune Lua System is indicated for the treatment of adult patients with unresect…


Novocure® does not review the information contained on this website and/or database for content, accuracy, or completeness. Use of and access to this information is subject to the terms, limitations, and conditions set by the website and/or database producer.

Novocure makes no representation as to the accuracy or any other aspect of the information contained on such website and/or database, nor does Novocure necessarily endorse such website and/or database.